Claudia Galassi
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
A novel mechanism of immunoevasion by ER+ breast cancer.
Journal: Trends in immunology
Published: December 09, 2025
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.
Journal: Nature cancer
Published: July 23, 2025
TIM-3 and γδ T cells: new players in breast cancer dissemination.
Journal: The EMBO journal
Published: July 19, 2025
An immunological mechanism of resistance to CDK4/6 inhibitors in HR+ breast cancer.
Journal: Oncoimmunology
Published: July 15, 2025
Epigenetic regulation of cancer stemness.
Journal: Signal transduction and targeted therapy
Published: April 10, 2025
CYPD limits HR+ mammary carcinogenesis in mice.
Journal: Cell death discovery
Published: March 19, 2025
Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort study.
Journal: Prostate cancer and prostatic diseases
Published: January 04, 2025
Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor-positive mammary carcinogenesis.
Journal: Journal of the National Cancer Institute
Published: October 18, 2024
Flow cytometry-assisted analysis of phenotypic maturation markers on an immortalized dendritic cell line.
Journal: Methods in cell biology
Published: October 11, 2024
Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Journal: Nature immunology
Published: September 17, 2024
Last Updated: 09/26/2026